Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.340 |
None |
1.000 |
4 |
|
2002 |
2007 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.330 |
None |
1.000 |
3 |
|
2006 |
2009 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.320 |
None |
1.000 |
2 |
|
2007 |
2009 |
Mammary Carcinoma, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
545
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Mammary Neoplasms, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
26 |
1
|
1999 |
2020 |
Meningioma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
634
|
43
|
0.100 |
None |
1.000 |
14 |
|
2000 |
2019 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.100 |
None |
1.000 |
11 |
|
1999 |
2019 |
Adult Meningioma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
405
|
30
|
0.100 |
None |
1.000 |
10 |
|
2000 |
2011 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.100 |
None |
1.000 |
10 |
|
1999 |
2019 |
Meningioma, benign, no ICD-O subtype
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
404
|
30
|
0.100 |
None |
1.000 |
10 |
|
2000 |
2011 |
Primary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3894
|
981
|
0.100 |
None |
1.000 |
10 |
|
1999 |
2019 |
Non-Small Cell Lung Carcinoma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3926
|
712
|
0.100 |
None |
1.000 |
10 |
|
2000 |
2018 |
Glomerular Filtration Rate
|
phenotype |
|
Diagnostic Procedure
|
399
|
1033
|
0.100 |
None |
1.000 |
5 |
4
|
2017 |
2019 |
Creatinine measurement, serum (procedure)
|
phenotype |
|
Laboratory Procedure
|
124
|
243
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.080 |
None |
1.000 |
8 |
|
2013 |
2020 |
Adenocarcinoma of lung (disorder)
|
disease |
Neoplasms
|
Neoplastic Process
|
2438
|
563
|
0.080 |
None |
1.000 |
8 |
|
1999 |
2017 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.080 |
None |
1.000 |
8 |
|
2012 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.080 |
None |
1.000 |
8 |
|
2013 |
2020 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.060 |
None |
1.000 |
6 |
|
2002 |
2017 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.040 |
None |
1.000 |
4 |
|
2000 |
2019 |
Lung Neoplasms
|
group |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1486
|
39
|
0.030 |
None |
1.000 |
3 |
|
2002 |
2006 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.030 |
None |
1.000 |
3 |
|
2012 |
2015 |
Neurofibromatosis 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
127
|
49
|
0.030 |
None |
1.000 |
3 |
|
2000 |
2010 |
Ependymoma
|
disease |
Neoplasms
|
Neoplastic Process
|
244
|
8
|
0.030 |
None |
1.000 |
3 |
|
2002 |
2016 |